ReachMD

Charles Potter has an engineering degree and PhD from Cambridge University. His PhD was carried out at Papworth Hospital, a specialist cardiothoracic centre in the UK, where he undertook research on heart transplantation. He subsequently spent 5 years working at PowderJect Pharmaceuticals where he gained a thorough grounding in novel drug delivery technologies. Charles is the inventor of the Glide Solid Dose Injector and also the CEO of Glide Pharma which is developing this exciting Glide SDI (Solid Dose Injector) technology.